JNJ Johnson & Johnson

Price (delayed)

$166.58

Market cap

$438.54B

P/E Ratio

24.57

Dividend/share

$4.19

EPS

$6.78

Enterprise value

$454.86B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
JNJ's price to earnings (P/E) is 66% lower than its 5-year quarterly average of 73.0 and 7% lower than its last 4 quarters average of 26.3
The gross profit is up by 16% YoY and by 3.3% QoQ
The quick ratio has decreased by 12% YoY

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.63B
Market cap
$438.54B
Enterprise value
$454.86B
Valuations
Price to earnings (P/E)
24.57
Price to book (P/B)
6.24
Price to sales (P/S)
4.8
EV/EBIT
22.98
EV/EBITDA
16.67
EV/Sales
4.97
Earnings
Revenue
$91.45B
EBIT
$19.8B
EBITDA
$27.28B
Free cash flow
$22.46B
Per share
EPS
$6.78
Free cash flow per share
$8.53
Book value per share
$26.69
Revenue per share
$34.74
TBVPS
$36.42
Balance sheet
Total assets
$179.23B
Total liabilities
$108.96B
Debt
$33.93B
Equity
$70.27B
Working capital
$15.33B
Liquidity
Debt to equity
0.48
Current ratio
1.34
Quick ratio
1.03
Net debt/EBITDA
0.6
Margins
EBITDA margin
29.8%
Gross margin
67.5%
Net margin
19.6%
Operating margin
24.7%
Efficiency
Return on assets
10.2%
Return on equity
26.6%
Return on invested capital
29.5%
Return on capital employed
14.7%
Return on sales
21.6%
Dividend
Dividend yield
2.52%
DPS
$4.19
Payout ratio
61.8%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
-0.31%
1 week
-1.89%
1 month
-0.98%
1 year
2.33%
YTD
-2.62%
QTD
-2.62%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$91.45B
Gross profit
$61.73B
Operating income
$22.58B
Net income
$17.88B
Gross margin
67.5%
Net margin
19.6%
The gross profit is up by 16% YoY and by 3.3% QoQ
The operating income rose by 15% year-on-year
JNJ's revenue is up by 13% year-on-year and by 2.5% since the previous quarter
Johnson & Johnson's net margin has decreased by 7% YoY

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
P/E
24.57
P/B
6.24
P/S
4.8
EV/EBIT
22.98
EV/EBITDA
16.67
EV/Sales
4.97
JNJ's price to earnings (P/E) is 66% lower than its 5-year quarterly average of 73.0 and 7% lower than its last 4 quarters average of 26.3
The EPS has grown by 5% YoY
JNJ's equity is up by 9% year-on-year
JNJ's price to book (P/B) is 8% more than its 5-year quarterly average of 5.8 but 2.5% less than its last 4 quarters average of 6.4
JNJ's revenue is up by 13% year-on-year and by 2.5% since the previous quarter
The price to sales (P/S) is 4.3% more than the 5-year quarterly average of 4.6 but 2% less than the last 4 quarters average of 4.9

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has decreased by 11% YoY and by 2.3% QoQ
The ROS has contracted by 9% YoY and by 5% from the previous quarter
The return on assets has declined by 3.8% year-on-year
The company's return on equity fell by 2.9% YoY

Dividends

What is JNJ's dividend history
DPS
$4.19
Dividend yield
2.52%
Payout ratio
61.8%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 64% greater than its total liabilities
The quick ratio has decreased by 12% YoY
JNJ's current ratio is down by 9% year-on-year and by 3.6% since the previous quarter
Johnson & Johnson's debt is 52% less than its equity
The company's debt to equity fell by 19% YoY
Johnson & Johnson's debt has decreased by 10% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.